| scholarly article | Q13442814 |
| P50 | author | Keith Wachowicz | Q57612504 |
| Atiyah Yahya | Q89834308 | ||
| P2093 | author name string | Edith Pituskin | |
| Nawaid Usmani | |||
| Matthew B Parliament | |||
| Nadeem Pervez | |||
| John Amanie | |||
| B Gino Fallone | |||
| Larissa J Vos | |||
| Oleksandr Boychak | |||
| Michele Janoski | |||
| P2860 | cites work | Value of 11C-choline PET and PET/CT in patients with suspected prostate cancer | Q34570356 |
| Guidance of treatment decisions in risk-adapted primary radiotherapy for prostate cancer using multiparametric magnetic resonance imaging: a single center experience | Q35131928 | ||
| Active surveillance: towards a new paradigm in the management of early prostate cancer | Q35648389 | ||
| Magnetic resonance imaging in prostate cancer | Q35980942 | ||
| Prostate MR imaging at high-field strength: evolution or revolution? | Q36254924 | ||
| Nomograms for prostate cancer | Q36532217 | ||
| How good is MRI at detecting and characterising cancer within the prostate? | Q36536899 | ||
| Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance? | Q36946494 | ||
| Active surveillance for favorable risk prostate cancer: what are the results, and how safe is it? | Q37033088 | ||
| Active surveillance for prostate cancer: overview and update | Q38074079 | ||
| Clinical use of novel urine and blood based prostate cancer biomarkers: a review | Q38157520 | ||
| Multiparametric magnetic resonance imaging characterization of prostate lesions in the active surveillance population: incremental value of magnetic resonance imaging for prediction of disease reclassification | Q38165661 | ||
| Magnetic resonance imaging in active surveillance of prostate cancer: a systematic review | Q38289798 | ||
| Preoperative prostate biopsy and multiparametric magnetic resonance imaging: reliability in detecting prostate cancer | Q38391587 | ||
| Expectant management of nonpalpable prostate cancer with curative intent: preliminary results | Q39593368 | ||
| Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression. | Q39597537 | ||
| Are extended biopsies really necessary to improve prostate cancer detection? | Q39659562 | ||
| How reliable is 12-core prostate biopsy procedure in the detection of prostate cancer? | Q41255229 | ||
| Modeling tracer kinetics in dynamic Gd-DTPA MR imaging | Q41352795 | ||
| Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancer | Q41686096 | ||
| Role for (11)C-choline PET in active surveillance of prostate cancer | Q41821490 | ||
| Imaging primary prostate cancer with 11C-Choline PET/CT: relation to tumour stage, Gleason score and biomarkers of biologic aggressiveness | Q42423216 | ||
| Pharmacokinetic mapping of the breast: a new method for dynamic MR mammography | Q42686047 | ||
| External validation of the updated partin tables in a cohort of French and Italian men. | Q44272478 | ||
| Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. | Q45216796 | ||
| Dual tracer 11C-choline and FDG-PET in the diagnosis of biochemical prostate cancer relapse after radical treatment. | Q45959752 | ||
| Validity of prostate-specific antigen as a tumour marker in men with prostate cancer managed by watchful-waiting: correlation with findings at serial endorectal magnetic resonance imaging and spectroscopic imaging | Q46564602 | ||
| Active surveillance for low-risk prostate cancer | Q57131939 | ||
| The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis | Q57392760 | ||
| The role of MRI-targeted and confirmatory biopsies for cancer upstaging at selection in patients considered for active surveillance for clinically low-risk prostate cancer | Q63966206 | ||
| Combined T2-Weighted and Diffusion-Weighted MRI for Localization of Prostate Cancer | Q63966352 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 410-418 | |
| P577 | publication date | 2016-04-01 | |
| P1433 | published in | World journal of radiology | Q27723340 |
| P1476 | title | Role of serial multiparametric magnetic resonance imaging in prostate cancer active surveillance | |
| P478 | volume | 8 |
| Q38781089 | Confirmatory biopsy of men under active surveillance: extended versus saturation versus multiparametric magnetic resonance imaging/transrectal ultrasound fusion prostate biopsy |
| Q93382450 | Role of multiparametric magnetic resonance imaging for patients under active surveillance for prostate cancer: a systematic review with diagnostic meta-analysis |
| Q98289988 | The role of multiparametric magnetic resonance imaging and magnetic resonance-guided biopsy in active surveillance for low-risk prostate cancer: A systematic review |
| Q38799211 | What is the best way not to treat prostate cancer? |
Search more.